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Mutations in hERG cause long QT syndrome type 2which is characterized by a prolonged
QT interval on electrocardiogram and predisposition to life-threatening ventricular
tachyarrhythmia, syncope, and sudden death. hERG-G572S induces trafficking defects
of hERG channel protein from Golgi to the plasma membrane and results in a
dominant negative suppression of hERG current density. As an accessory β subunit,
KCNE2 promotes hERG migration from Golgi to cellular membrane. In this study, we
investigated the rescue effect of KCNE2 in a G572S mutation of hERG. Transfection
was performed into HEK293 cells. Patch clamp technique, western blotting analyses
and confocal microscopic examination were used. Results showed that KCNE2 had
a significantly enhanced effect on G572S mutation current. The increase of current
was largest at KCNH2:KCNE2 of 1:3. Confocal images showed co-expressing G572S
and KCNE2 could cause a substantial up-regulated membrane protein (155 kDa)
expression. Expression of membrane protein accumulated markedly with increasing
ratio of KCNH2:KCNE2. G572S defective mutant could be restored by both KCNE2
and lower temperature (27◦C), which suggested that the lower temperature could
be the favorable circumstances for the rescue function of KCNE2. In this study,
we successfully set up “the action potential” on the HEK 293 cells by genetically
engineered to express Kir2.1, Nav1.5, and Kv11.1, wherein on reaching over an
excitation threshold by current injection. The results suggested thatKCNE2 could shorten
action potential duration which was prolonged by G572S. These findings described
electrophysiological characteristics of the LQT2 syndrome mutation KCNH2-G572S and
regulation by accessory protein KCNE2, and provided a clue about LQT2 and relative
rescue mechanism.
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INTRODUCTION
Human hereditary long QT syndrome (LQTS) is a heterogeneous cardiac repolarization disorder
characterized by a prolonged QT interval on the surface electrocardiogram (Schwartz et al., 2012).
The human-ether-a-go-go-related gene (hERG orKCNH2) encodes the pore-forming alpha subunit
of K+ channel that resembles the rapid component of delayed rectifier current (IKr) in cardiac
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myocytes (Warmke and Ganetzky, 1994; Sanguinetti et al.,
1995; Trudeau et al., 1995). Mutations in hERG cause long QT
syndrome type 2 (LQT2) (Sanguinetti et al., 1995; Schweigmann
et al., 2014), which is characterized by a prolonged QT interval
on electrocardiogram and predisposition to life-threatening
ventricular tachyarrhythmia, syncope and sudden death (Saenen
and Vrints, 2008).
In 1999, Abbott et al. described that MiRP1 formed stable
assemblies with hERG and the resulting channel complex had
functional attributes like those of native, cardiac IKr channels.
There are discrepancies among investigators in describing the
effects of KCNE2 on hERG currents (Abbott et al., 1999; Mazhari
et al., 2001; Weerapura et al., 2002; Eldstrom and Fedida, 2011).
Previous studies showed that KCNE2 could modulate single
channel conductance (Abbott et al., 1999), gating kinetics (Zhang
et al., 2001), the rate of protein degradation (Zhang et al.,
2012), regulate hERG endocytosis, alter some aspects of hERG
pharmacology (Dupuis et al., 2005) and promote hERGmigration
from Golgi to cellular membrane as an accessory β subunit (Um
and McDonald, 2007).
It is estimated that at least 80% of missense mutations in
KCNH2 result in defects in assembly and hence trafficking of
functional channels to the plasma membrane (Anderson et al.,
2006; Walker et al., 2007). The considerable work has been
undertaken looking at pathways of hERG trafficking and the role
of chaperones in detecting misfolded mutant proteins (Thomas,
2003). To our knowledge, hERG-G572S induces trafficking
defects of hERG channel protein from Golgi to the plasma
membrane and results in a dominant negative suppression
of hERG current density. hERG-G572S channel subunits can
coassemble with WT subunits, and this results in retention of
WT subunits within the ER. In silico modeling it is found that
G572S would cause a significant prolongation of AP duration
(Zhao et al., 2009).
As mentioned above, we speculated KCNE2 could have
some effects on hERG-G572S. This study sought to research
electrophysiological characteristics of KCNH2-G572S and
regulation of KCNE2 on KCNH2-G572Smutation.
MATERIALS AND METHODS
Site-Directed Mutagenesis and
Transfection into HEK293 Cells
The G572S mutation was introduced into the KCNH2 cDNA by
directed mutagenesis (QuickChange Site-Directed Mutagenesis
kit, Stratagene). The Wild-type (WT) and mutant SCN5A
were also inserted in frame into a pcDNA3.1 vector plasmid
(Invitrogen) to be expressed. Sequence analysis was used to
confirm the presence of themutation.WT andmutant ofKCNH2
were transiently transfected inHuman embryonic kidney (HEK)-
293 cells. HEK293 cells were transiently transfected with 1.2µg of
the KCNH2 construct, either WT or G572S, using Lipofectamin
2000 (Life Technologies, Gaithersburg, MD, USA) according to
the manufacturer’s protocol. The green fluorescent protein (GFP)
gene was as a reporter gene in co-transfection HEK293 cells with
plasmid. After 6 h, the transfection medium was replaced with
regular medium. Transfected HEK293 cells were cultured for 48–
72 h. Only cells exhibiting green fluorescence were separated by
enzymatic treatment and seeded in plastic Petri dishes bottomed
with a coverslip. Using the patch-clamp technique, currents were
recorded.
Patch Clamp Recording
hERG currents were recorded at room temperature using the
whole-cell patch-clamp configuration with the MultiClamp 700B
amplifier (Axon Instruments). Data were sampled at 10 kHz and
filtered at 5 kHz subsequently for analysis (Digidata 1440A, Axon
Instruments). Recording pipettes were pulled from borosilicate
capillary tubes by using P-97 programmable patch micropipette
horizontal puller (Sutter Instruments). Micropipette resistance
ranged from 2.0 to 5.5 M when filled with the internal solution
and immersed in the external solution. To minimize voltage
clamp errors, series resistance (Rseries) was compensated by
<2.0 M and usually ≥80% compensation was achieved in
all experiments. The membrane capacitance was compensated
by approximately 80∼90% of their initial value. The internal
solution contained (in mM): K aspartate 85, KCl 45, Na pyruvate
5, K2ATP 3, MgCl2 4, EGTA 10, HEPES 10, and glucose 11,
adjusted to pH 7.2 with KOH. Cells were perfused with an
external (bath) solution containing (in mM): NaCl 140, CaCl2 1,
MgCl2 1, KCl 4, HEPES 10, and glucose 5, adjusted to pH 7.4 with
NaOH.
To record the INa, cells were bathed in a solution that
contained (in mM) NaCl 40, CaCl2 2, CsCl 5, MgCl2 1.2,
HEPES 10, and glucose 5, adjusted to pH 7.4 with CsOH. The
glass pipettes were filled with a solution of (in mM) CsCl 60,
caesium aspartate 80, EGTA 11, HEPES 10, Na2ATP 5, at pH 7.2,
adjusted with CsOH. To avoid current drift of INa, sodium ion
concentration of external (bath) solution was set at 40 uM, room
temperature was kept at 20◦C, micropipette of 0.5 µm-inner
diameter was used, and micropipette resistance ranged from 0.5
to 1 M when filled with the internal solution and immersed in
the external solution (Sokolov et al., 2013).
To record AP, cells were bathed in a solution that contained
(in mM) NaCl 137, KCl 5.9, CaCl2 2.2, MgCl2 1.2, glucose 14,
and HEPES 10. The pH of the solution was adjusted to 7.4 with
NaOH. The pipette solution for whole-cell recordings contained
(in mM) KCl 140, MgCl2 4, HEPES 10, Na2ATP 2, and EGTA
0.05. The pH of the pipette solution was adjusted to 7.2 with KOH
(Fujii et al., 2013).
Western Blotting Analyses
Total homogenates were obtained from HEK293 cells using
standard methods (Zhou et al., 1998). Blots were probed
with primary antibodies against Kv11.1. Chemiluminescent
detection was performed with substrate reagents from Pierce
Biotechnology. Densitometric analysis was performed with
Image for Windows software (V. Beta 4.0.2; Scion). The
expression level of Kv11.1 protein was monitored using Western
blotting analyses. HEK293 cells expressing KCNH2-G572S were
lysed, and the total proteins (TP) were extracted. Moreover,
the total protein membrane (PM) was purified using a plasma
membrane protein extraction kit according to the manufacturer’s
instructions (Biovision, Inc. USA). TP or PM (150µg) per sample
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was separated by 10% SDS-PAGE and blotted onto nitrocellulose
membrane (Stratagene, La Jolla, CA). Subsequently, hERG
protein was detected using primary antibodies against Actin
(Affinity Reagents), the specific polyclonal rabbit anti-hERG
antibody (Santa Cruz Biotechnology, CA) and goat anti-rabbit
Alexa Fluor 700 (Molecular Probes, Eugene, OR, dilution
1:2000). Densitometry and the Scion Image Software (Scion,
Frederick, MD) were used to quantify the band densities. All data
were normalized against Actin (n= 3).
Confocal Microscopy Examination
HEK293 cells were transfected with different hERG plasmids
(pcDNA3-WT-hERG, pcDNA3-G572S-hERG and pcDNA3-
KCNE2). Forty eight hours later, HEK 293 cells were fixed in 4%
paraformaldehyde, treated with 0.1% Triton X-100, and blocked
with 3% bovine serum albumin (BSA) at room temperature.
These cells were then stained with rabbit polyclonal anti-hERG
(1:50 dilution, Alomone, Israel) and mouse monoclonal anti-
KCNE2 (1:100 dilution, Abcam, MA, USA) at 4◦C overnight,
followed by incubation with Alexa Fluor 488 goat anti-rabbit IgG
and Alexa Fluor 555 goat anti-mouse IgG at 37◦C for 2 h. Stained
cells were examined under a confocal microscope (FV10i,
Olympus, Japan) for subcellular location of hERG protein.
The Assay System for Action Potential
To investigate the effect of G572S-hERG mutation on action
potential duration, we built a cell system in which sodium
(Nav1.5) channels, inward rectifier potassium channel (Kir2.1)
and hERG potassium channels were co-expressed according
to Fujii reported (Fujii et al., 2012). HEK293 cells with
stable expression of SCN5A cDNA (Nav1.5) were transfected
with 2.0 µg hERG cDNA (Kv11.1) and 2.0 µg KCNJ2 cDNA
(Kir2.1) according to Lipofectamine method (Life Technologies,
Gaithersrburg, MD, USA) suggested by the manufacturer. CD8
cDNAwas co-transfected to be used as a reporter gene (EBo-pCD
vector, American Type Culture Collection). CD8-positive cells
identified using Dynabeads (Dynal, M-450 CD8) were patch-
clamped 48–72 h after transfection.
Data Analysis
Data are expressed as means ± S.E. Voltage protocols and data
analysis were done with pCLAMP 10.2 (Axon Instruments)
and Origin 6.1 (Microcal Software). Student’s t-test was used
for statistical analysis between the experimental groups (two-
tailed). For multiple group comparisons, statistical significance
was determined by ANOVA. With a ANOVA followed by
a Student-Newman-Keuls (S-N-K) post hoc test, significance
between any two groups was evaluated. P-values lower than
0.05 were considered statistically significant. The mid-point of
activation was obtained using a Boltzmann function where G =
[1+ exp(V1/2-V) /k]
−1, where V1/2 and k are the mid-point and
the slope factor, respectively, and G = I/(V-Vrev) where Vrev
is the reversal potential and V is the membrane potential. The
steady state of inactivation was also fitted using the Boltzmann
equation. With a two-exponential function, the time constants of
inactivation were assessed. All data were fitted using a nonlinear
least-squares minimization method.
RESULTS
Effect of KCNE2 on KCNH2-G572S
Currents
The step and tail currents ofKCNH2 elicited upon from a holding
potential of −90 mV, the membrane potential was stepped from
−50 to +60 mV for 2000 ms, and then repolarized to −40
mV for 3000 ms to elicit outward tail current. The standard
protocol was applied with a start-to-start interval of 15 s. First
of all, to define the functional changes of the mutation G572S,
whole-cell currents of WT or G572S mutant channels were
recorded respectively, without KCNE2. Currents recorded from
WT channel showed the typical hERG current traces: relatively
slow activation and deactivation with an inwardly rectifying
profile. Compared with WT, tail current densities of G572S
significantly decreased. After co-transfecting with KCNE2, tail
current densities of G572S and WT were both significantly
increased. At +60 mV, tail current densities of WT and G572S
before and after co-transfecting with KCNE2 were 65.4 ± 3.6 vs.
110.4 ± 7.5 pA/pF of WT and 10.2 ± 1.2 vs. 89.4 ± 6.4pA/pF
of G572S (n = 10, P < 0.01). We found that KCNE2 had a more
significantly enhanced effect on G572Smutation current than on
WT (Figures 1A,B). To test the effects of KCNE2 quantity, we
used the different ratio of 3:1, 1:1, and 1:3 of KCNH2:KCNE2
in the experiment. The results showed the current was largest at
KCNH2-G572S:KCNE2 of 1:3 (Figure 1C).
Effect of KCNE2 on Current-Voltage
Relationship Curve of KCNH2-G572S
Currents
As shown in Figure 2A, I-V relationship curve for step currents
of G572S was significantly lower than that of WT between
−10 and +20 mV, indicating there was a more obvious
reduction in G572S amplitudes compared to in WT. When
co-expressing KCNE2, G572S and WT currents were both
significantly enhanced. As shown in Figure 2B, I-V relationship
curve for tail current of G572S was lower than that of WT over
+10 mV of test potentials and enhancement of G572S currents
by KCNE2 was more prominent than that of WT (n = 10, p <
0.01).
Effect of KCNE2 on Gating Kinetics of
KCNH2-G572S Currents
The steady-state activation was assessed using standard tail
current analysis. Cells were depolarized to potentials in the
range −60 to +30 mV (4 s) and tail current was recorded
at −120 mV. The steady-state inactivation currents for G572S
and WT were measured with the following protocol: Channels
were inactivated under double-pulse model with condition pulse
depolarization +20 mV (1 s) and following short test pulses
to potentials ranging from −120 to +20 mV (15 ms, 10 mV-
increments) that was applied to recover the channels from
inactivation. Returning to the holding potential of +20 mV
evoked large outward inactivating currents. Tail current data
were normalized to the maximum current value and fitted with
Boltzmann function. Either V1/2 or k of steady-state activation
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FIGURE 1 | Effect of KCNE2 on KCNH2-G572S current. Compared with WT, tail current of G572S is significantly decreased. After co-transfecting KCNH2 and
KCNE2, tail currents of G572S and WT are significantly increased (A). A more significant enhancement of mutation current is found than WT by KCNE2 at test
potential of +60 mV. After co-transfecting with KCNE2, tail current densities of G572S and WT were both significantly increased. KCNE2 had a more significantly
enhanced effect on G572S mutation current densities than on WT (B). Due to the different proportion of KCNH2: KCNE2, the currents are different, furthermore,
current is the largest at KCNH2: KCNE2 of 1:3. n = 10, **P < 0.01 and ***P < 0.001 (C).
and inactivation of G572S mutant were similar to that of WT,
and the parameters of steady-state activation and inactivation do
not change after co-transfecting KCNE2 and KCNH2. Fast time
constants of deactivation of G572S and WT were similar either
with or without KCNE2. Slow time constants of deactivation of
G572S and WT with co-expressed KCNE2 were shorter at range
of test potentials (Figure 3).
Effect of KCNE2 on Protein Expression of
KCNH2-G572S Channel
To further investigate the regulation of KCNE2 on G572S
mutation, subcellular localization of mutant proteins in the
cell surface was examined. Confocal images were taken from
the HEK293 cells expressing WT, G572S, and G572S-KCNE2,
respectively. The images showed the localization of hERG
protein on cell membrane. Cells expressing WT had a marked
surface membrane localization of hERG; whereas the cells
expressing G572S apparently had a reduced fluorescent intensity
on membrane surface. When co-transfecting HEK293 cells with
G572S and KCHE2, the fluorescent intensity on membrane
surface increased (Figure 4A).
WT channel protein on western blot was present in both
immature core-glycosylated form of 135 kDa that was localized
to the ER and mature complexly glycosylated form of 155 kDa
that was inserted into the cell membrane (Zhou et al., 1998;
Ficker et al., 2003). To investigate the expression of hERG protein
of G572S mutation, western blotting analyses of the different
fractions were performed. Figure 4B showed that in the case
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FIGURE 2 | Effect of KCNE2 on current-voltage relationship curve of KCNH2-G572S current. I-V relationship curve for step currents of G572S is lower than
that of WT between −10 and +20 mV of test potentials and G572S and WT currents are significantly enhanced by KCNE2 (A). I-V relationship curve for tail current of
G572S is lower than that of WT over +10 mV of test potentials and increase of G572S currents (n = 10, P < 0.001) by KCNE2 is more significant than WT (n = 10,
P < 0.01) (B).
of WT, co-transfecting with KCNE2 increased the expression
of hERG protein on the plasma membrane (155 kDa) without
affecting the total protein content in whole cell homogenates.
Compared with WT, G572S channel mature protein fraction
in the region of the cell membrane (155 kDa) was markedly
decreased while non-mature protein (135 kDa) had no change.
Co-expressing G572S and KCNE2 could cause a substantial up-
regulated membrane protein (155 kDa) expression. Furthermore,
expression of membrane protein accumulated markedly with
increasing ratio of KCNH2:KCNE2. This result showed there
was more membrane protein (155 kDa) expression at KCNH2-
G572S:KCNE2 of 1:3 in current study. Protein expressing
both of KCNH2-WT:KCNE2 of 3:1and KCNH2-WT:KCNE2
of 1:1 were also increased, however, the increase rate was
smaller than KCNH2-WT:KCNE2 of 1:3. The result showed that
KCNE2 maybe had rescue effect on trafficking dysfunction of
G572S. This experiment was repeated three times (P < 0.01)
(Figure 4B).
Rescue Effects of KCNE2 on G572S
Mutation under the Condition of Low
Temperature
It has been reported that there is temperature-dependent
rescuing effect in some trafficking-deficient mutations of hERG
protein, such as R752W, G601S, and N470D. Low temperature
culturing of cells has been reported to increase the surface
expression of many hERG mutants. To examine whether
this temperature-dependent rescuing effect worked for G572S
mutant, representative western blot analysis of hERG protein
expression was performed at 37◦C and 27◦C, respectively. It
was obtained that matured protein (155 kDa) of G572S mutant
were 31.6% at 27◦C and 17.2% at 37◦C. This result showed
that exposure of cells at 27◦C restored the matured protein
(155 kDa) expression of G572S, compared with at 37◦C. With
co-expression of KCNE2, matured protein (155 kDa) of G572S
mutant were increased to 92.5% at 27◦C and 68.4% at 37◦C,
respectively. These results suggested that lower temperature
could be the favorable circumstance for the rescue function of
KCNE2 (Figure 5).
Building of “The Action Potential (AP)” by
Co-Transfecting SCN5A, KCNJ2, and
KCNH2 into HEK293 Cells
HEK 293 cell line was utilized as a proof-of-concept unexcitable
somatic cell source based on its low levels of endogenous
membrane currents, uniform shape and growth, and extensive
use as a heterologous expression system for studies of ion
channel function (Thomas and Smart, 2005). We chose three
basic components of action potential. KCNJ2 (Kir2.1,) channel
maintained the resting membrane potential, SCN5A (Nav1.5)
channel mainly contributed 0 phase depolarzion of AP, and
KCNH2 (Kv11.1) had critical role in repolarization of AP. To
verify subcellular localization of Nav1.5, Kir2.1, and Kv11.1
proteins, distribution of three channels was detected by confocal
microscopy. Images demonstrated that Nav1.5, Kir2.1, and
Kv11.1 proteins were stable co-expressed on the HEK293
cell membrane (Figure 6A). To assess whether these proteins
expressing on cell membrane were functional, we recorded INa,
IK1, and IKr currents in voltage clamp mode using whole-cell
patch-clamp technique respectively (Figure 6B). Three currents
were recorded, which indicated co-transfection or co-expression
was successful. Subsequently, we applied current injection ranged
from 900 to 1500 pA for 5 ms to stimulus HEK293 cell. AP was
found on the oscilloscope with a shorter AP duration with 9.2
± 0.2 ms of 50% repolarization of APD (APD50) and 49.5 ±
2.7 ms of 90% repolarization of APD (APD90). Action potential
amplitudes (APA) were 108.5 ± 3.4 mV and resting membrane
potentials (RMP) were−70.1± 1.2 mV (Figure 6C).
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FIGURE 3 | Effect of KCNE2 on gating kinetics of KCNH2-G572S current. Tail current data were normalized to the maximum current value and fitted with
Boltzmann function. Either V1/2 or k of steady-state activation and inactivation of G572S mutant is similar to that of WT and the parameters steady-state activation
and inactivation do not change after co-transfecting KCNE2 and KCNH2 (A,B). Fast time constants of deactivation of G572S andWT are similar either with or without
KCNE2. Slow time constants of deactivation of G572S and WT with co-expressed KCNE2are shorter at range of test potentials (C).
Rescue Effect of KCNE2 on Action
Potential Composed of KCNH2-G572S
To demonstrate the contribution of KCNE2 on
shortening the APD prolonged by G572S, we established
Kir2.1+Nav1.5+Kv11.1-G572S HEK293 cell line, and AP was
recorded with/without co-expressing KCNE2. Figure 7A showed
the two representative AP traces and visually, KCNE2 could
shorten the APD which was prolonged by G572S. APD90
of G572S and WT were 85.7 ± 4.5 ms and 49.5 ± 2.7 ms
respectively. APD90 of G572S after co-transfecting with KCNE2
were shortened to 56.2 ± 3.3 ms (n = 10, P < 0.01). This
suggested that KCNE2 could rescue APD prolonged by G572S.
Furthermore, different ratio of 3:1, 1:1, and 1:3 ofKCNH2:KCNE2
was used in the experiment. The most significantly rescue effect
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FIGURE 4 | Rescue effect of KCNE2 on protein expression of
KCNH2-G572S channel. Confocal images were taken from the HEK293 cells
expressing WT, G572S, and G572S-KCNE2, respectively. The
immunofluorescence images showed the localization of hERG protein on cell
membrane. The hERG-GFP labeling on the cell membrane was shown in
green, while the chromatin-DAPI was shown in blue (A). Western blot analysis
of the expression of KCNH2-G572S and KCNH2-WT channel protein was
performed in transfected HEK293 cells. G572S channel mature protein
fraction in the region of the cell membrane (155 kDa) is markedly decreased
than that of WT, but when co-transfecting KCNE2, the membrane protein (155
kDa) expression substantially increased. Due to the different proportion of
KCNH2: KCNE2, the membrane protein (155 kDa) expression are different,
furthermore, the expression is the largest at KCNH2: KCNE2 of 1:3. n = 10,
**P < 0.01, vs. WT group; ##P < 0.01, vs. G572S group (B).
was at KCNH2: KCNE2 of 1:3 which was in accord with the
effect of KCNE2 on G572S mutation current. (n = 10, P < 0.01,
Figures 7B,C).
DISCUSSION
In this experiment, we first found KCNE2 could significantly
increase the tail current densities of KCNH2-G572S mutation.
FIGURE 5 | Rescue effects of KCNE2 on G572S mutation at lower
temperature. Representative western blot analysis of the hERG protein
expression was performed at 37◦C and 27◦C with/without KCNE2,
respectively (A). The matured protein of G572S was increased at 27◦C
compared with at 37◦C, which was inferred by the appearance of the 155-kDa
protein in western blot analysis. Furthermore, co-transfecting G572S with
KCNE2 led to another substantial increase of membrane protein expression
both at 37◦ and 27◦C. (n = 3) **P < 0.01, vs. WT group; ##P < 0.01, vs.
G572S group (B).
Previous experiments have shown that KCNH2-G572S mutation
led to loss of channel function, with a significantly lower current
and amarkedly prolongation of action potential duration andQT
interval in electrocardiogram (Splawski et al., 2000; Napolitano
et al., 2005; Tester et al., 2005). Our results suggest that KCNE2
restores the channel function, increases both WT and G572S
current and shortens the APD prolonged by G572S.
Protein processing and trafficking may play an important
and regulated role in controlling channel characteristics (Geva
and Schuldiner, 2014). To our knowledge, there are two main
reasons why the loss of function happen following channel gene
mutant (Sanguinetti et al., 1996; Thomas, 2003): (1). Change of
the gating dynamics causes a decline current; (2). The trafficking
defect of channel protein to the cell membrane gives rise to
down-regulation of the membrane channel proteins and reduces
current. hERG channels are translated and initially glycosylated
at the endoplasmic reticulum (ER, molecular weight of hERG
protein is 135 kDa) (Petrecca et al., 1999). After folding properly
with the assistance of chaperones, hERG channels are trafficking
to the Golgi for secondary glycosylation (molecular weight of
hERG protein is 155 kDa) and then further trafficking to the
membrane (Gong et al., 2002; Smith et al., 2011). In this study,
our results showed that the cells expressing G572S apparently
had a reduced fluorescent intensity and maturation membrane
protein (155 kDa) expression on membrane surface. These
rusults suggested that G572S maybe led to channel protein
migration defects. We have focused on the physical protein-
protein association and trafficking of KCNE2 and hERG. After
co-transfection with KCNE2, membrane protein expression of
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FIGURE 6 | New building of the action potential by co-transfecting Nav1.5, Kir2.1, and KCNH2 into HEK293 cells. Distribution of three channels was
detected by confocal microscopy. Images demonstrated that Nav1.5, Kir2.1, and Kv11.1 proteins were stable co-expressed on the HEK293 cell membrane (A).
Schematic representation of the voltage-clamp protocol and the representative Nav1.5, Kir2.1, and KCNH2 current traces (B). Action potentials were structured by
Nav1.5, Kir2.1, and Kv11.1 channel porteins in the HEK293 cells (C).
G572S mutation and hERG currents densities are increased
significantly. The small proteins encoded by KCNE2 have been
proposed as accessory subunits for the hERG channel (Abbott
et al., 1999). So, it is supported the concept that assembly ofKCNE
proteins with K+ channels happens early in the biosynthetic
process, probably in the ER (Shi et al., 1996; Krumerman et al.,
2004; McKeown et al., 2008). KCNE2 can promote the Kv11.1
channel protein to traffic the cell surface and expression of
membrane protein (Um and McDonald, 2007). This may partly
explain the rescue mechanism of KCNE2 on G572Smutations in
this study.
Mutations in different locations of the hERG potassium-
channel gene are associated with different levels of risk for
arrhythmic cardiac events in LQT2, with the greatest risk related
tomutations in the critical pore region of the channel (Moss et al.,
2002). G572S is a hERG pore domain mutation which locates
in the short linker between the fifth transmembrane domain
and the 5-P α-helix of the pore domain. The placement of the
inactivation helix (between the S5- and pore helix) is based on
functional studies. Anderson et al. speculated that the location
of amino acid substitutions in putative Kv11.1-helical or-sheet
domains appears to correlate with the trafficking-deficient and
mutations disrupted Kv11.1 channel biogenesis (Anderson et al.,
2006). Based on this speculation, we hypothesize that KCNE2
propably correct the change of the protein space structure caused
by G572S, and this correction could stabilize the channel protein
in configurations that facilitate proper trafficking.
As we have known, at lower temperatures, an increased
ER retention time might make an improved channel folding.
Additionally, a reduced incubation temperature could reverse
the mutant’s effects on hERG currents according to inhibition
of proteasomal degradation and therefore increase the surface
expression of these hERG mutants (Thomas et al., 2003). At
physiological temperatures mutant channels cannot pass quality
control processes of the ER and do not reach the plasma
membrane. At reduced temperatures, protein folding might be
altered and ultimately permitted exit from the ER (Ficker et al.,
2000). It has been reported that low temperature could correct
hERG defective protein trafficking, thus increase the surface
expression of some LQT2-causing mutants, such asG601S,K28E,
N407D, and A422T (Zhou et al., 1999; Gong et al., 2006; Chen
et al., 2007; Guo et al., 2012). G572S has a dominant negative
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FIGURE 7 | Rescue effect of KCNE2 on action potential composed of KCNH2-G572S. New building action potential was recorded by using clamp-patch
technique (A). It was found that prolongation of APD50 and APD90 of G572S mutant were both significantly shortened by KCNE2. Due to the different proportion of
KCNH2: KCNE2, this rescue effect by KCNE2 were different, furthermore, the most significantly rescue effect was at KCNH2: KCNE2 of 1:3. (n = 10), **P < 0.01, vs.
WT group; #P < 0.05, vs. G572S group; ##P < 0.01, vs. G572S group (B,C).
trafficking defect and a severe phenotype (Zhao et al., 2009). In
our research, matured protein expression of G572S was found to
be restored by lower incubation temperature, which is similar
to those mutations with trafficking defect mentioned above.
This result supported G572S was likely a temperature-sensitive
mutation localized to the transmembrane domain. Based on our
observation, KCNE2 induced a more effectively up-regulation
of matured protein (155 kDa) expression of G572S at lower
temperature, which has not been reported before. However, the
molecular mechanism responsible for this phenomenon remains
to be analyzed in the future.
In the study about mechanism of ion channel diseases, it
is indispensable to evaluate the effect of mutation channels on
the action potential. However, subculture of the myocardial cell
isolation is difficult. Other difficulties lie in cellular toxicity of
transfection reagents and low transfection efficiency. Besides,
low differentiation rate of induced pluripotent stem cells (iPS)
limits to its application (Müller et al., 2013). Although computer
simulation can better reflect the effects of mutations channel
of action potential (ten Tusscher et al., 2004), it is unable to
objectively reflect the real situation. It was reported that the
HEK 293 cells genetically engineered to stably express both
SCN5A, KCNJ2,much like primary excitable cells, could develop
membrane excitability. wherein on reaching an excitation
threshold by current injection, they reproducibly fired an “all-
or-none” AP (Kirkton and Bursac, 2011). We chose resting
potential current of IK1, depolarization current of INa and major
repolarization current of IKr to build an action potential and
then a typical sample of myocardial cell-like action potential
was recorded. However, it seems to be different from the
classic AP. The possible reason might be a lack of calcium
channel which contributes to the repolaration plateau of action
potential.
By using the above system, we found hERG-G572S was a loss
of function mutation which could lead a reduction of hERG
current densities and could prolong APD of HEK 293 cell line
established in our research. However, withKCNE2 co-expression,
hERG current density increased and the APD was significantly
shortened. This assay system which was used to evaluate function
of hERG channel genetic mutations in our research is a useful tool
because of its simplicity and high cost performance.
The findings in this study described electrophysiological
characteristics of the LQT2 syndrome mutation KCNH2-G572S
and regulation by accessory protein KCNE2. The study provided
a clue about LQT2 and relative rescue mechanism. It might
prompt a certain treatment of KCNE2 on LQT2.
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